US FDA Recommends Tests, Documentation To Show Benzene No Higher Than 2PPM In Drugs

CDER says guidance needed to help facilitate and expedite reformulating drug products which use carbomers manufactured with benzene, a human carcinogen, so that no more than 2 parts per million of the substance is present.